BD211

· Shanghai BDgene Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BD211, covering 2024-06-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major [Phase 1]

See pricing